Oxycontin earned them $2.8 billion last year but drug companies have a tiny window in which they can make any money so they are always looking for creative ways to extend that. Even a 6-month extension is a billion bucks so Purdue is putting together a pediatric trial which will involve 154 children ages 6 to 16 that would finish in August, 2013.
Obviously for children in pain the ability of doctors to go 'off-label' is a good thing, but this isn't just about the kids. And the data on what an opiod could do to a very young brain basically does not exist.
PAINKILLERS FOR KIDS by Karen Keller, The Daily.com
Comments